US Markets Round-Up

This week, the Russell 3000 index, an important benchmark of the US stock market across market capitalizations, started on a marginally positive note and made a new lifetime high of 2599.68. However, the index witnessed correction from the higher levels in the latter part of the week and closed at 2572.35 with a week till date (WTD) loss of ~0.98 percent on July 08, 2021. Other major indices such as S&P 500 and NASDAQ Composite also showed negative movement during the week. On July 08, 2021, the S&P 500 index settled at 4320.82 with a WTD loss of ~0.72 percent, while NASDAQ Composite Index settled at 14559.79 with a WTD loss of ~0.54 percent.

An increase in the US weekly unemployment claims coupled with a decline in Service PMI acted as the major factors for the downward direction. As per the data released by the US Bureau of Labor Statistics, US weekly unemployment claims increased to 373,000 from 371,000 (revised level) in the prior week. The ISM Service PMI (data released by the Institute for Supply Management) for the month of June-21 registered 60.1 percent compared to 64 percent in May-21 and further acted as a catalyst for a bearish movement. 

Having understood the US market performance over the week, taking cues from major global news, and based on our technical analysis of the Russell 3000 index for the upcoming week, now let us have a look at the two NYSE/ NASDAQ listed stock picks from the technical standpoint. Noted below are our recommendations based on generic insights, entry price, target prices, and stop-loss for Fiverr International Ltd (NYSE: FVRR) and ADC Therapeutics SA (NYSE: ADCT) for the next 2-4 weeks duration:

Fiverr International Ltd 

Fiverr International Ltd (NYSE: FVRR) is an Israel-based online marketplace. The company provides a platform for freelancers to provide services to customers worldwide. Noted below are the key price indicators for the stock:

Price Action Analysis (on the Weekly Chart) 

FVRR's price broke a falling wedge (bullish continuation) pattern on the upside on May 24, 2021 and has since then been trading above the breakout level, indicating an upside direction for the stock. Prices are continuously taking support from 21-period SMA and for the short-term (2-4 weeks), we may expect upside movement in the stock. Now the next major resistance level appears at USD 295.00, and prices may test that level in the coming sessions.

Technical Indicators Analysis (On the Weekly Chart)

On the weekly chart, RSI is trading at ~56.08 levels and indicating a positive trend for the stock. The weekly volumes also seem supportive of an upside movement. The CMP is above the 21-period and 50-period SMA with a positive crossover, further providing support for an upward direction.

Financial Summary:

Summary of the Key Financial Metrics for the past four years for Fiverr International Ltd is as follows:

General Recommendation:

As per the above-mentioned price action and technical indicators analysis, we can conclude that Fiverr International Ltd is looking technically well-placed on the chart, and we have a ‘Buy’ rating on the stock. Investment decision should be made depending on an investors’ appetite on upside potential, risks, and any previous holdings. This recommendation is purely based on technical analysis, and fundamental analysis has not been considered in this report. The summary of our recommendation is as follows:

ADC Therapeutics SA

ADC Therapeutics SA (NYSE: ADCT) is a Switzerland-based biotechnology company. It is engaged in the development of antibody-drug conjugates (ADCs), used in the treatment of both solid and hematological cancers. Noted below are the key price Indicators for the stock:

Price Action Analysis (on the Weekly Chart) 

ADCT's price recovered from the lower levels after forming a positive divergence with the RSI (14-period) and currently, trading above a downward sloping trend line breakout, indicating an upward direction for the stock. Now the next major resistance level appears at USD 28.75, and prices may test that level in the short-term (2-4 weeks). A further breakout above USD 28.75 backed by volumes may extend buying in the stock to USD 30.60 level.

Technical Indicators Analysis (On the Weekly Chart)

On the Weekly chart, RSI is trading at ~46.17 levels and recovered from the lower levels, indicating a positive trend for the stock. The weekly volumes also seem supportive of an upside movement. The 21-period SMA is hovering around CMP and supporting an upside direction; however, prices are trading below 50-period SMA, acting as a resistance zone for the stock.

Financial Summary: 

Summary of the Key Financial Metrics for the past four years for ADC Therapeutics SA is as follows: 

General Recommendation:

As per the above-mentioned price action and technical indicators analysis, we can conclude that ADC Therapeutics SA is looking technically well-placed on the chart, and we have a ‘Speculative Buy’ rating on the stock. Investment decision should be made depending on an investors’ appetite for upside potential, risks, and any previous holdings. This recommendation is purely based on technical analysis, and fundamental analysis has not been considered in this report. The summary of our recommendation is as follows:

Upcoming Major Global Economic Events

Market events occur on a day-to-day basis depending on the frequency of the data and generally include an update on employment, inflation, GDP, consumer sentiments, etc. Noted below are the upcoming week's major global economic events that could impact the Russell 3000 Index and stocks’ prices.

Investment Related Risks: Based on the technical analysis, the risks are defined as per risk-reward ratio (~0.60:1.00), however, returns are generated within 2-4 weeks’ time frame. This may be looked at by Investors with sufficient risk appetite looking for returns within short investment duration. Investment recommendations provided in this report are solely based on technical parameters, and fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, and social and political instability risks etc.

Entry Price: For the given recommendation(s), Entry Price is assumed be at or above a certain level. However, a slight deviation on either side in the ‘Entry Price’ can be considered depending upon the potential expected or indicated.

Note 1: Note 1: Investors can consider exiting from the stock if the Target Price mentioned as per the technical analysis has been achieved and subject to the factors discussed above. 

Note 2: How to Read the Charts?

The Green colour line reflects the 21-period moving average while the red line indicates the 50- period moving average. SMA helps to identify existing price trend. If the prices are trading above the 21-period and 50-period moving average, then it shows prices are currently trading in a bullish trend.

The Black colour line in the chart’s lower segment reflects the Relative Strength Index (14-Period) which indicates price momentum and signals momentum in trend. A reading of 70 or above suggests overbought status while a reading of 30 or below suggests an oversold status.

The Blue colour bars in the chart’s lower segment show the volume of the stock. The volume is the number of shares that changed hands during a given day. Stocks with high volumes are more liquid than stocks with lesser volume as liquidity in stocks helps in easier and faster execution of the order.

The Orange colour lines are the trend lines drawn by connecting two or more price points and used for trend identification purposes. The trend line also acts as a line of support and resistance.

Technical Indicators Defined: -

Support: A level where-in the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.

Resistance: A level where-in the stock prices tend to find resistance when they are rising, and uptrend may take a pause due to profit booking or selling interest.

Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.

Risk Reward Ratio: Risk reward ratio is the difference between an entry point to a stop loss and profit level. We suggest ~60% Stop Loss of the Target 1 from the entry point. 

A trailing stop-loss is a modification of stop-loss in case of favourable movement in the price to protect the gains. We suggest Investors to Trail the Stop-Loss as per the aforementioned levels if the stock price achieves more than 60% of the Target 1. Investors should consider exiting from the position as per the Trailing Stop-Loss level if the price starts moving downwards after achieving more than 60% of the Target 1. 

The reference date for all price data, volumes, technical indicators, support, and resistance levels is July 08, 2021. The reference data in this report has been partly sourced from REFINITIV. 

Abbreviations

CMP: Current Market Price

SMA: Simple Moving Average

RSI: Relative Strength Index

USD: United States dollar 

Note: Trading decisions require a thorough analysis by investors. Technical reports in general chart out metrics that may be assessed by investors before any stock evaluation. The above are illustrative analytical factors used for evaluating the stocks; other parameters can be looked at along with additional risks per se. Past performance is neither an indicator nor a guarantee of future performance.

Disclaimer

References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.

This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.